Did you mean
vaccines

Search results - 14 results

Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx

Publication Type: Peer reviewed scientific article Authors: Konnova, Angelina; De Winter, Fien H. R.; Gupta, Akshita; Verbruggen, Lise; Hotterbeekx, An; Berkell, Matilda; Teuwen, Laure-Anne; Vanhoutte, Greetje; Peeters, Bart; Raats, Silke; Massen, Isolde ...

Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.

Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; Desombere, Isabelle; Ariën, Kevin K; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Keywords: Adult ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)

2 (27/09-24/10) the percentage of adults (18 years or older) with anti- SARS-CoV-2 antibodies has increased from 69.5% to 90.4%. This substantial increase is in line with the intensive vaccination campaign during ...

Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:

Publication Type: Peer reviewed scientific article Authors: Debie, Yana; Van Audenaerde, Jonas R.M.; Vandamme, Timon; Croes, Lieselot; Teuwen, Laure-Anne; Verbruggen, Lise; Vanhoutte, Greetje; Marcq, Elly; Verheggen, Lisa; Le Blon, Debbie; Peeters, Bart; ...

Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study

period, which coincided with the onset of the vaccination campaign, the seroprevalence in the population increased from 25.2% in March/April to 78.1% in July. Among the vaccinated there was an increase from ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study

community dwelling population aged 18 years and above had developed anti- SARS-CoV-2 antibodies. This percentage was 98.9% among fully vaccinated people (since at least 2 weeks before being tested) and 28.9% ...

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.

care and in possible future vaccination strategies, and co-infections in children younger than 5 years should be considered during diagnosis and treatment. Our findings support the use of national ...

Consultations Corona: Participation citoyenne à la politique Belge de vaccination

COVID-19 participation citoyenne Vaccination Abstract: Le but des consultations corona était de faire en sorte que différents groupes de citoyens belges puissent délibérer d’une manière informée sur les ...

Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants

Health Topics:  Efficacité et sécurité des vaccins, médicaments et produits de santé- Qualité des laboratoires médicaux Coronavirus Santé et environnement Effectiveness and safety of vaccines, medicines ...

Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection.

of future RT-qPCR tests, as well as verifying that the former methods are still capable of detecting circulating SARS-CoV-2 variants. Health Topics:  Effectiveness and safety of vaccines, medicines and ...

QR code

QR code for this page URL